Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for intravenous administration. It is commonly associated with clot-busting therapies and is manufactured by Boehringer Ingelheim Italia S.P.A.

Actilyse is primarily used to dissolve blood clots in conditions like ischemic stroke and pulmonary embolism. It works by activating plasminogen, which helps break down fibrin in blood clots. This medication is often used in emergency settings to restore blood flow and prevent tissue damage.

Common effects of Actilyse may include bleeding at the injection site or other areas of the body. Some individuals might experience allergic reactions or changes in blood pressure. It is important to monitor for any unusual symptoms while using this medication.

Actilyse should be handled with care to avoid contamination. It is crucial to follow proper administration procedures to minimize the risk of bleeding complications. Patients with a history of bleeding disorders or recent surgery should use this medication under close medical supervision.

Actilyse may interact with anticoagulants, antiplatelet drugs, and other medications that affect blood clotting. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of this medication.